On the last day of the regular session, the Louisiana Legislature settled two major debates: A bill that would have banned ...

The president wants a the most-favored-nation pricing model. But the U.S. drug industry is offering a host of reasons why ...

What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

BATON ROUGE, La. (Louisiana Illuminator) - A low heat that’s simmered for weeks over an attempt to lower prescription drug prices in Louisiana increased to a boil Thursday in the waning hours of the ...

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

WASHINGTON — The Trump administration is pushing pharmaceutical companies to begin negotiations to bring their drug prices in ...

A day after Gov. Kim Reynolds signed a bill into law that's aimed at helping keep rural pharmacies in business but could also lead to higher drug costs for Iowans, some local pharmacy owners across ...

The Minnesota government remains barred from enforcing its law prohibiting certain price hikes on generic drugs after a ...

Adopting most-favored-nation pricing could save hundreds of billions of dollars along the way to holding PBMs more ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The transparency bill passed on the final day of the legislative session. It requires PBMs to disclose how much they pay pharmacies and the prices they negotiate for medications. The goal is to make ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.